Castle Biosciences, Inc. (CSTL) Q3 2021 Earnings Results

Castle Biosciences Misses on EPS, Stock Up 3.29%

Castle Biosciences reported a larger-than-expected loss per share, which typically raises concerns among investors. However, the stock rose by 3.29%, indicating that investors may have reacted positively to other aspects of the company's performance or future potential, despite the EPS miss.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.47	N/A	-36.23%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Castle Biosciences Misses on EPS, Stock Up 3.29%

Key numbers

Management commentary

Castle Biosciences, Inc.

More earnings this week

Castle Biosciences Misses on EPS, Stock Up 3.29%

Key numbers

Management commentary